Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
81.99
-0.08 (-0.10%)
Aug 5, 2026, 4:00 PM EDT - Market closed

BridgeBio Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
16,02814,8985,2157,0681,1482,458
Market Cap Growth
78.19%185.69%-26.22%515.81%-53.30%-71.87%
Enterprise Value
17,58016,1836,2758,3682,3713,352
Last Close Price
81.9976.4927.4440.377.6216.68

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
27.6429.6723.50759.7714.7835.25
PB Ratio
--7.14-3.55-5.22-0.91-2.82

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
30.3132.2328.28899.5130.5448.08

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.86-0.89-1.18-1.29-1.38-1.99
Net Debt / Equity Ratio
-0.68-0.61-0.71-0.95-0.97-1.02
Net Debt / EBITDA Ratio
-2.99-2.46-1.79-2.14-2.40-1.56
Net Debt / FCF Ratio
-3.49-2.85-2.01-2.43-2.86-1.74
Asset Turnover
0.500.540.300.020.090.08
Inventory Turnover
0.951.57----
Quick Ratio
1.402.524.443.154.346.34
Current Ratio
1.522.774.673.324.526.58
Return on Equity (ROE)
33.59%41.48%38.81%50.49%45.93%154.80%
Return on Assets (ROA)
-45.51%-56.45%-81.08%-103.88%-62.62%-67.19%
Return on Invested Capital (ROIC)
-87.30%-74.13%-101.80%-134.35%-74.27%-131.91%
Return on Capital Employed (ROCE)
-87.31%-74.09%-101.58%-134.35%-74.27%-77.63%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-1.99%-2.93%-14.30%-10.39%-2.16%-22.34%
Total Shareholder Return
-1.99%-2.93%-14.30%-10.39%-2.16%-22.34%
SEC Filings: 10-K · 10-Q